Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

t57,

That should go up.


Kaiser is big,

"http://providers.kaiserpermanente.org/info_assets/cpp_ga/pdfs/ga_formularyupdate_June2015.pdf";


Bottom of page 2,

New Standing Orders

"Approved standing orders are written instructions issued by medical practitioners, in accordance with the regulations, authorizing pharmacy personnel at pharmacies owned or operated by Kaiser Foundation Health Plan to supply and administer specified medications under circumstances specified in the order.
Copaxone 20 mg/ml injection will be changed to glatiramer acetate 20 mg/ml injec- tion via standing order. The FDA recently approved Glatopa, a generic or biosimilar version of Copaxone 20 mg/ml."


In doing some searching, I see there are 200 new cases of MS a week. Sooner or later we are taking off like a certain persons hockey stick graph. I suspect, the first quarter next year might well get quite interesting with new plan benefit changes.

Boing X 2